Evidence map›Paper›PMID 34154564›Full record

ArticleBMC public health2021

Examining the impact of the early stages of the COVID-19 pandemic period on youth cannabis use: adjusted annual changes between the pre-COVID and initial COVID-lockdown waves of the COMPASS study.

Scott T Leatherdale, Richard E Bélanger, Rabi Joël Gansaonré, Karen A Patte, Margaret deGroh, Ying Jiang, Slim Haddad

Abstract read
In one paragraph

Article in BMC public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Suicide Risk Factors in High School Students.International journal of environmental research and public health · 2024
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Taking Stock of the Downstream Effects of COVID-19 on Youth Substance Use Risk.The Journal of adolescent health : official publication of the Society for Adolescent Medicine · 2022
    Article
  16. Perceptions of and adherence to early COVID-19-related restrictions and associations with substance use among youth in Canada.Health promotion and chronic disease prevention in Canada : research, policy and practice · 2022
    Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Scott T LeatherdaleSchool of Public Health Sciences, University of Waterloo, 200 University Avenue, Waterloo, ON, N2L 3G1, Canada. sleather@uwaterloo.ca.
Richard E BélangerVITAM - Centre de recherche en santé durable, Université Laval, Quebec, Canada.
Rabi Joël GansaonréVITAM - Centre de recherche en santé durable, Université Laval, Quebec, Canada.
Karen A PatteDepartment of Health Sciences, Brock University, St. Catharines, Canada.
Margaret deGrohApplied Research Division, Public Health Agency of Canada, Ottawa, Canada.
Ying JiangApplied Research Division, Public Health Agency of Canada, Ottawa, Canada.
Slim HaddadVITAM - Centre de recherche en santé durable, Université Laval, Quebec, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGiven the high rates of cannabis use among Canadian youth and that adolescence is a critical period for cannabis use trajectories, the purpose of this paper was to examine the effect of the early stages of the COVID-19 pandemic period on youth cannabis use in the context of a natural experiment. We used 3-year linked data from the COMPASS study, including 7653 Canadian (Quebec, Ontario) adolescents from which 1937 completed all 3 survey waves (pre-COVID-19 [2018, 2019] and online [2020] during the early pandemic period [May-July 2020]). Structural equation modeling (SEM) and double difference (DD) models were used to estimate pre-COVID-19 to initial COVID-19 pandemic period change (2019-2020) in cannabis use (monthly, weekly, daily) compared to 2018 to 2019 change to adjust for age-related effects. Models were adjusted for age of entry into the cohort and sociodemographic characteristics.

resultsIn the SEM and DD models, monthly, weekly, and daily cannabis use increased across all waves; however, the expected increases from the pre-COVID-19 wave (2019) to the initial COVID-19 period wave (2020) were lesser relative to the changes seen across the 2018 to 2019 waves. The cross-sectional data from May to July 2020 identified that the majority of youth who use cannabis did not report increased cannabis use due to COVID-19 or using cannabis to cope with COVID-19.

conclusionDuring the early stages of the COVID-19 pandemic period, there does not appear to be a detrimental effect on youth cannabis use, when adjusted for age-related changes. Further prospective research is needed to explore the impact of the ongoing pandemic response on youth cannabis use onset and progression.

Indexed as

CannabisCOVID-19AdolescentCommunicable Disease ControlCross-Sectional StudiesHumansOntarioPandemicsQuebecSARS-CoV-2AdolescentsCannabisCohortCOVID-19PandemicProspectiveYouth

Identifiers

PMID34154564
PMCPMC8215868

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.